http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2273494-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2000-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5020888b6f3d84e4f57460d8656c041b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810b6e1a4ea7b319f93dba6aa9429bb1 |
| publicationDate | 2006-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2273494-C2 |
| titleOfInvention | New indications for applying mannan-binding lectin when treating immune-compromised individuals |
| abstract | FIELD: medicine. n SUBSTANCE: method involves introducing to a mammal therapeutic dose of drug having at least one subunit or at least one oligomer of mannan-binding lectin comprising one mannan-binding lectin subunit. n EFFECT: reduced risk of infection development; enhanced effectiveness in acting upon agents resistant to usual therapy. n 43 cl, 2 dwg |
| priorityDate | 1999-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.